AB321. SPR-48 The effects of myrbetriq on detrusor overactivity associated with suprasacral spinal cord injury (SCI) in rats

OBJECTIVE: β3-adrenoceptor agonists (BARA) represent a novel mechanism of action for direct relaxation of urinary bladder smooth muscle. Myrbetriq (MYR) is an FDA approved BARA developed by Astellas Pharma, and has proven to be very useful for treating overactive bladder. Preliminary data from this...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Androl Urol
Asıl Yazarlar: Brooks, Jillene M., Degoski, Danielle J., Fraser, Matthew O.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2016
Konular:
Abstract
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5143270/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s321
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller